Early Coronary Angiography in Patients With Out-of-Hospital Cardiac Arrest Without ST-Segment Elevation: A Systematic
Rahul Gupta1, Amir Hossein Behnoush2, Amirmohammad Khalaji2
1From the Lehigh Valley Heart Institute, Lehigh Valley Health Network, Allentown, PA.
Insights
Early coronary angiography (CAG) in non-ST-elevation myocardial infarction patients showed lower in-hospital and mid-term mortality in overall analyses. However, randomized controlled trials (RCTs) did not confirm this benefit, suggesting limitations in current evidence.
Area of Science:
- Cardiology
- Interventional Cardiology
- Clinical Research
Background:
- Out-of-hospital cardiac arrest carries a high mortality rate.
- The benefit of early coronary angiography (CAG) in non-ST-elevation myocardial infarction (NSTEMI) is debated.
- Distinguishing outcomes between randomized controlled trials (RCTs) and observational studies is crucial.
Conclusions:
- Early CAG is associated with reduced in-hospital and mid-term mortality in overall meta-analyses of NSTEMI patients.
- However, evidence from RCTs does not support a significant mortality benefit, highlighting potential limitations in generalizability to real-world practice.
- Further research is needed to clarify the role of early CAG in diverse patient populations with NSTEMI.
Abstract:
Out-of-hospital cardiac arrest has a high mortality rate. Unlike ST-elevation myocardial infarction, the results of performing early coronary angiography (CAG) in non-ST-elevation myocardial infarction patients are controversial. This study aimed to compare early and nonearly CAG in this population, in addition to the identification of differences between randomized controlled trials (RCTs) and observational studies conducted in this regard. A systematic search in PubMed, Embase, and Cochrane library was performed to identify the relevant studies. Random-effect meta-analysis was done to calculate the pooled effect size of early versus nonearly CAG outcomes in all studies in addition to each of the RCT and observational subgroups of the studies. The relative risk ratio (RR), along with its 95% confidence interval (CI), was used as a measure of difference. A total of 16 studies including 5234 cases were included in our analyses. Compared with observational cohorts, RCT studies had patients with higher baseline comorbidities (older age, hypertension, diabetes, and coronary artery disease). Random-effect analysis revealed a lower rate of in-hospital mortality in the early-CAG group (RR, 0.79; 95% CI, 0.65-0.97; P = 0.02); however, RCT studies did not find a statistical difference in this outcome (RR, 1.01; 95% CI, 0.83-1.23; P = 0.91). Moreover, mid-term mortality rates were lower in the early-CAG group (RR, 0.87; 95% CI, 0.78-0.98; P = 0.02), mostly due to observational studies. There was no significant difference between the groups in other efficacy and safety outcomes. Although early CAG was associated with lower in-hospital and mid-term mortality in overall analyses, no such difference was confirmed by the results obtained from RCTs. Current evidence from RCTs may not be representative of real-world patients and should be interpreted within its limitation.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome IV: Interprofessional Care
Imaging Studies for Cardiovascular System V: CT
Angina III: Clinical Manifestations and Assessment


